Genentech

OCREVUS

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Genentech

Ocrevus HCPCS:

J2350

HCPCS Code Descriptor:

Injection, ocrelizumab, 1 mg

Category:

J Code

Ocrevus NDCs:

50242-0150-01

Primary Type:

Neurology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Ocrevus CPT Codes:

-96413, 96415, 96365, 96366, 99601, 99602 *More information on the CPT codes can be found here https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/OCREVUS-Billing-Coding-for-MS.pdf

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Ocrevus:

OCREVUS is a Neurology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J2350 is aligned to the drug OCREVUS.

ACCESS PRICING AND MORE BY REGISTERING

J2350 Added Date:

January 1, 2018

J2350 Effective Date:

January 1, 2018

J2350 Termination Date:

HCPCS Active

Ocrevus billing and coding information can be found through Genentech at the link below:
Ocrevus patient assistance information can be found through Genentech at the URL: https://www.gene.com/patients/patient-foundation
OCREVUS prescribing information can be found at the link below:
Information regarding OCREVUS’s side effects can be found at MedlinePlus